📰 Maximize Shareholder News
Maximize Shareholder News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Maximize Shareholder. Real-time updates on events, politics, business and more.
March 25, 2024
Article - Braemar Hotels & Resorts Rejects Director Nomination Notice from Blackwells Capital - The Board has unanimously determined that the Blackwells Nomination Notice is invalid due to numerous deficiencies, most notably a failure to disclose the funds true objectives - which Braemar believes include an underhanded attempt to effectuate a takeover of the Company without paying an adequate price.
January 8, 2024
/PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today reported preliminary, unaudited fourth quarter and full year 2023 net product revenue...
January 5, 2024
/PRNewswire/ -- Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) ("Hollysys" or the "Company") today announced that it will hold an extraordinary general...
July 17, 2023
Vote AGAINST the Reelection of Entrenched Stratasys Board at Annual General Meeting ("AGM") to Be Held on August 8th, 2023 Stratasys Board Has Repeatedly Neglected Its Fiduciary Duties to the Detriment of Its
July 14, 2023
Multiple Alternatives Exist to the Desktop Metal Transaction That Offer Significantly Better Terms for Stratasys Shareholders Expects Stratasys Board to Quickly Deem 3D Systems Offer Superior to...
July 14, 2023
Multiple Alternatives Exist to the Desktop Metal Transaction That Offer Significantly Better Terms for Stratasys Shareholders Expects Stratasys Board to...
July 14, 2023
Multiple Alternatives Exist to the Desktop Metal Transaction That Offer Significantly Better Terms for Stratasys Shareholders
June 23, 2023
Mercury Systems to Focus on Enhanced Execution of Strategic Plan Under Refreshed Leadership Team
April 3, 2023
Turning the Page; A Promising FutureLOS ANGELES, April 03, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Accelerated Pre-Investigational New Drug (Pre-IND) submission to the US Food and Drug Administration
April 3, 2023
Turning the Page; A Promising FutureLOS ANGELES, April 03, 2023 -- -- Accelerated Pre-Investigational New Drug submission to the US Food and Drug Administration for potential cancer... | April 3, 2023